Data gathered: November 22
AI Stock Analysis - TransMedics Group (TMDX)
Analysis generated September 28, 2024. Powered by Chat GPT.
TransMedics Group, Inc. (NASDAQ: TMDX) is an innovative medical technology company specializing in organ transplant systems. Their flagship product, the Organ Care System (OCS), revolutionizes organ preservation, making it possible to monitor and maintain organs in a near-physiologic, functioning state outside the body. The company's breakthrough technology aims to improve the outcomes of organ transplantation, targeting significant unmet needs in the healthcare industry.
Stock Alerts - TransMedics Group (TMDX)
 |
TransMedics Group | November 22 Price is down by -6% in the last 24h. |
|
TransMedics Group | November 20 Price is down by -6.8% in the last 24h. |
|
TransMedics Group | November 15 Price is down by -5.2% in the last 24h. |
|
TransMedics Group | November 14 Price is down by -5.1% in the last 24h. |
Alternative Data for TransMedics Group
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 21 | Sign up | Sign up | Sign up |
| Sentiment | 91 | Sign up | Sign up | Sign up |
| Webpage traffic | 45,000 | Sign up | Sign up | Sign up |
| Employee Rating | 64 | Sign up | Sign up | Sign up |
| Google Trends | 11 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Instagram Followers | 1,943 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 22 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 4,762 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,294 | Sign up | Sign up | Sign up |
| Twitter Mentions | 21 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 758 | Sign up | Sign up | Sign up |
| News Mentions | 2 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 46 | Sign up | Sign up | Sign up |
| Linkedin Employees | 477 | Sign up | Sign up | Sign up |
About TransMedics Group
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
| Price | $76.04 |
| Target Price | Sign up |
| Volume | 2,600,000 |
| Market Cap | $2.59B |
| Year Range | $70.86 - $176.11 |
| Dividend Yield | 0% |
| PE Ratio | 83.01 |
| Analyst Rating | 88% buy |
| Industry | Medical Devices |
In the news
 |
Canaccord Genuity Group Lowers TransMedics Group (NASDAQ:TMDX) Price Target to $104.00November 22 - ETF Daily News |
|
Natixis Advisors LLC Has $12.26 Million Stake in TransMedics Group, Inc. (NASDAQ:TMDX)November 21 - ETF Daily News |
 |
TD Cowen Cuts TransMedics Group (NASDAQ:TMDX) Price Target to $120.00November 20 - ETF Daily News |
 |
Is TransMedics Group Stock a Buy?November 15 - Biztoc.com |
|
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Bought by Los Angeles Capital Management LLCNovember 14 - ETF Daily News |
|
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Purchased by Principal Financial Group Inc.November 12 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 109M | 48M | 61M | 4.2M | 4M | 0.120 |
| Q2 '24 | 114M | 45M | 69M | 12M | 16M | 0.350 |
| Q1 '24 | 97M | 37M | 60M | 12M | 16M | 0.350 |
| Q4 '23 | 81M | 33M | 48M | 4M | 6.3M | 0.120 |
| Q3 '23 | 66M | 26M | 41M | -25M | -23M | -0.780 |
Insider Transactions View All
| Hassanein Waleed H filed to sell 61,643 shares at $135. October 17 '24 |
| Hassanein Waleed H filed to sell 61,943 shares at $134.2. October 17 '24 |
| Hassanein Waleed H filed to sell 63,143 shares at $132.8. October 17 '24 |
| Hassanein Waleed H filed to sell 66,661 shares at $131.9. October 17 '24 |
| Khayal Tamer I filed to sell 20,977 shares at $153.8. October 3 '24 |
Similar companies
Read more about TransMedics Group (TMDX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of TransMedics Group?
The Market Cap of TransMedics Group is $2.59B.
What is TransMedics Group's PE Ratio?
As of today, TransMedics Group's PE (Price to Earnings) ratio is 83.01.
What is the current stock price of TransMedics Group?
Currently, the price of one share of TransMedics Group stock is $76.04.
How can I analyze the TMDX stock price chart for investment decisions?
The TMDX stock price chart above provides a comprehensive visual representation of TransMedics Group's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling TransMedics Group shares. Our platform offers an up-to-date TMDX stock price chart, along with technical data analysis and alternative data insights.
Does TMDX offer dividends to its shareholders?
As of our latest update, TransMedics Group (TMDX) does not offer dividends to its shareholders. Investors interested in TransMedics Group should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of TransMedics Group?
Some of the similar stocks of TransMedics Group are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.